Véronique Quillien

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy et al. · JNCI Journal of the National Cancer Institute · 2002 · 600 citations · Full text

DNA methylation in glioblastoma: impact on gene expression and clinical outcome

Amandine Etcheverry, Marc Aubry, Marie de Tayrac et al. · BMC Genomics · 2010 · 218 citations · Full text

Comparative assessment of 5 methods (methylation‐specific polymerase chain reaction, methylight, pyrosequencing, methylation‐sensitive high‐resolution melting, and immunohistochemistry) to analyze O6‐methylguanine‐DNA‐methyltranferase in a series of 100 glioblastoma patients

Véronique Quillien, Audrey Lavenu, Lucie Karayan‐Tapon et al. · Cancer · 2012 · 200 citations

Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods

Lucie Karayan‐Tapon, Véronique Quillien, Joëlle Guilhot et al. · Journal of Neuro-Oncology · 2009 · 183 citations

Neuro-oncology, Oncology, Medicine +11

Dual <scp>IRE</scp> 1 <scp>RN</scp> ase functions dictate glioblastoma development

Stéphanie Lhomond, Tony Avril, Nicolas Dejeans et al. · EMBO Molecular Medicine · 2018 · 169 citations · Full text